Peregrine Capital Management LLC Ocular Therapeutix, Inc Transaction History
Peregrine Capital Management LLC
- $2.82 Billion
- Q1 2025
A detailed history of Peregrine Capital Management LLC transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Peregrine Capital Management LLC holds 847,468 shares of OCUL stock, worth $6.88 Million. This represents 0.22% of its overall portfolio holdings.
Number of Shares
847,468Holding current value
$6.88 Million% of portfolio
0.22%Shares
1 transactions
Others Institutions Holding OCUL
# of Institutions
190Shares Held
133MCall Options Held
374KPut Options Held
179K-
Summer Road LLC West Palm Beach, FL13.9MShares$113 Million98.85% of portfolio
-
Deep Track Capital, LP Greenwich, CT12.8MShares$104 Million4.83% of portfolio
-
Vr Adviser, LLC New York, NY12.8MShares$104 Million17.98% of portfolio
-
Black Rock Inc. New York, NY11.5MShares$93.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.48MShares$68.9 Million0.0% of portfolio
About OCULAR THERAPEUTIX, INC
- Ticker OCUL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,966,896
- Market Cap $625M
- Description
- Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...